[1]
Shaha, K.B., Adhikari, A., Cho, J.R., Pandey, B., Sharma, Y. and Safi, S. 2020. Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth. Nepalese Medical Journal. 3, 1 (May 2020), 309–312. DOI:https://doi.org/10.3126/nmj.v3i1.28726.